Literature DB >> 22699930

Challenging the effectiveness of green tea in primary and tertiary cancer prevention.

Hirota Fujiki1, Kazue Imai, Kei Nakachi, Masahito Shimizu, Hisataka Moriwaki, Masami Suganuma.   

Abstract

PURPOSE: Drinking green tea daily is part of Japanese culture, and various studies have revealed that green tea is a cancer preventive. We here review our progress in cancer prevention with green tea on 12 main topics, from basic to clinical level. TOPICS AND METHODS: Biochemical and biological studies of green tea catechins, a prospective cohort study, preclinical safety trials with tablets of green tea extract, double-blind randomized clinical phase II prevention trial for recurrence of colorectal adenomas, and synergistically enhanced inhibition by the combination of green tea catechins and anticancer drugs. All results were significant, including human studies with informed consent.
RESULTS: Drinking 10 Japanese-size cups of green tea per day delayed the cancer onset of humans 7 years for females. For tertiary cancer prevention, consuming 10 cups of green tea per day fortified by green tea tablets, 50 %, significantly prevented the recurrence of colorectal adenomas. A minimum effective amount of green tea catechins for cancer prevention was found in humans. In addition, the combination of green tea catechins and anticancer drugs engendered a new cancer therapeutic strategy.
CONCLUSION: The consumption of 10 Japanese-size cups of green tea per day is a significant factor in primary cancer prevention for the general population, and the preventive effect on recurrence of colorectal adenomas in patients is vital evidence in tertiary cancer prevention.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22699930     DOI: 10.1007/s00432-012-1250-y

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  61 in total

Review 1.  Green tea consumption and breast cancer risk or recurrence: a meta-analysis.

Authors:  Adeyemi A Ogunleye; Fei Xue; Karin B Michels
Journal:  Breast Cancer Res Treat       Date:  2009-05-13       Impact factor: 4.872

2.  Inhibition of N-nitrosodiethylamine- and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced tumorigenesis in A/J mice by green tea and black tea.

Authors:  Z Y Wang; J Y Hong; M T Huang; K R Reuhl; A H Conney; C S Yang
Journal:  Cancer Res       Date:  1992-04-01       Impact factor: 12.701

3.  Cancer-preventive effects of drinking green tea among a Japanese population.

Authors:  K Imai; K Suga; K Nakachi
Journal:  Prev Med       Date:  1997 Nov-Dec       Impact factor: 4.018

Review 4.  Cancer prevention with green tea and monitoring by a new biomarker, hnRNP B1.

Authors:  H Fujiki; M Suganuma; S Okabe; E Sueoka; N Sueoka; N Fujimoto; Y Goto; S Matsuyama; K Imai; K Nakachi
Journal:  Mutat Res       Date:  2001-09-01       Impact factor: 2.433

5.  Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: a preliminary report from a one-year proof-of-principle study.

Authors:  Saverio Bettuzzi; Maurizio Brausi; Federica Rizzi; Giovanni Castagnetti; Giancarlo Peracchia; Arnaldo Corti
Journal:  Cancer Res       Date:  2006-01-15       Impact factor: 12.701

6.  Green tea extracts for the prevention of metachronous colorectal adenomas: a pilot study.

Authors:  Masahito Shimizu; Yasushi Fukutomi; Mitsuo Ninomiya; Kazuo Nagura; Tomohiro Kato; Hiroshi Araki; Masami Suganuma; Hirota Fujiki; Hisataka Moriwaki
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-11       Impact factor: 4.254

7.  Carcinogenic potential of tobacco tar-resistant Staphylococcus aureus in buccal cavity.

Authors:  H Fujiki; H Takeuchi; N Nishitani; H Yamanaka; K Suzuki; M Kurusu; M Suganuma
Journal:  J Cancer Res Clin Oncol       Date:  2004-03-11       Impact factor: 4.553

8.  The inhibitory effect of (-)-epigallocatechin gallate on activation of the epidermal growth factor receptor is associated with altered lipid order in HT29 colon cancer cells.

Authors:  Seiji Adachi; Tomokazu Nagao; Helgi I Ingolfsson; Frederick R Maxfield; Olaf S Andersen; Levy Kopelovich; I Bernard Weinstein
Journal:  Cancer Res       Date:  2007-07-01       Impact factor: 12.701

9.  Inhibition of N-methyl-N'-nitro-N-nitrosoguanidine-induced carcinogenesis by (-)-epigallocatechin gallate in the rat glandular stomach.

Authors:  T Yamane; T Takahashi; K Kuwata; K Oya; M Inagake; Y Kitao; M Suganuma; H Fujiki
Journal:  Cancer Res       Date:  1995-05-15       Impact factor: 12.701

10.  Protocol for minimizing the risk of metachronous adenomas of the colorectum with green tea extract (MIRACLE): a randomised controlled trial of green tea extract versus placebo for nutriprevention of metachronous colon adenomas in the elderly population.

Authors:  Julia C Stingl; Thomas Ettrich; Rainer Muche; Martina Wiedom; Jürgen Brockmöller; Angela Seeringer; Thomas Seufferlein
Journal:  BMC Cancer       Date:  2011-08-18       Impact factor: 4.430

View more
  12 in total

Review 1.  Tea and human health: biomedical functions of tea active components and current issues.

Authors:  Zong-mao Chen; Zhi Lin
Journal:  J Zhejiang Univ Sci B       Date:  2015-02       Impact factor: 3.066

Review 2.  Synergistic enhancement of anticancer effects on numerous human cancer cell lines treated with the combination of EGCG, other green tea catechins, and anticancer compounds.

Authors:  Hirota Fujiki; Eisaburo Sueoka; Tatsuro Watanabe; Masami Suganuma
Journal:  J Cancer Res Clin Oncol       Date:  2014-12-28       Impact factor: 4.553

3.  Green tea catechins in combination with irinotecan attenuates tumorigenesis and treatment-associated toxicity in an inflammation-associated colon cancer mice model.

Authors:  Gaurab Borah; Manuj Kumar Bharali
Journal:  J Egypt Natl Canc Inst       Date:  2021-07-26

4.  Quantitative comparison of cancer and normal cell adhesion using organosilane monolayer templates: an experimental study on the anti-adhesion effect of green-tea catechins.

Authors:  Rumi Sakamoto; Eisuke Kakinuma; Kentaro Masuda; Yuko Takeuchi; Kosaku Ito; Kentaro Iketaki; Takahisa Matsuzaki; Seiichiro Nakabayashi; Hiroshi Y Yoshikawa; Hideaki Yamamoto; Yuko Sato; Takashi Tanii
Journal:  In Vitro Cell Dev Biol Anim       Date:  2016-06-01       Impact factor: 2.416

Review 5.  Tumor promoters: from chemicals to inflammatory proteins.

Authors:  Hirota Fujiki; Eisaburo Sueoka; Masami Suganuma
Journal:  J Cancer Res Clin Oncol       Date:  2013-06-12       Impact factor: 4.553

Review 6.  Effect of Tea Polyphenol Compounds on Anticancer Drugs in Terms of Anti-Tumor Activity, Toxicology, and Pharmacokinetics.

Authors:  Jianhua Cao; Jie Han; Hao Xiao; Jinping Qiao; Mei Han
Journal:  Nutrients       Date:  2016-12-14       Impact factor: 5.717

Review 7.  Cancer Prevention with Green Tea and Its Principal Constituent, EGCG: from Early Investigations to Current Focus on Human Cancer Stem Cells.

Authors:  Hirota Fujiki; Tatsuro Watanabe; Eisaburo Sueoka; Anchalee Rawangkan; Masami Suganuma
Journal:  Mol Cells       Date:  2018-01-31       Impact factor: 5.034

Review 8.  Phorbol esters in seed oil of Jatropha curcas L. (saboodam in Thai) and their association with cancer prevention: from the initial investigation to the present topics.

Authors:  Hirota Fujiki; Maitree Suttajit; Anchalee Rawangkan; Keisuke Iida; Pornngarm Limtrakul; Sonthaya Umsumarng; Masami Suganuma
Journal:  J Cancer Res Clin Oncol       Date:  2017-01-25       Impact factor: 4.553

9.  Relationships between black tea consumption and key health indicators in the world: an ecological study.

Authors:  Ariel Beresniak; Gerard Duru; Genevieve Berger; Dominique Bremond-Gignac
Journal:  BMJ Open       Date:  2012-11-08       Impact factor: 2.692

10.  Green Tea (-)-Epigallotocatechin-3-Gallate Induces PGC-1α Gene Expression in HepG2 Cells and 3T3-L1 Adipocytes.

Authors:  Mak-Soon Lee; Seohyun Lee; Miae Doo; Yangha Kim
Journal:  Prev Nutr Food Sci       Date:  2016-03-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.